Ladislav Volicer - Publications

Affiliations: 
University of South Florida, Tampa, FL, United States 

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Volicer L. Physiological and pathological functions of beta-amyloid in the brain and alzheimer's disease: A review. The Chinese Journal of Physiology. 63: 95-100. PMID 32594062 DOI: 10.4103/CJP.CJP_10_20  0.309
2020 Kaasalainen S, Hunter PV, Dal Bello-Haas V, Dolovich L, Froggatt K, Hadjistavropoulos T, Markle-Reid M, Ploeg J, Simard J, Thabane L, van der Steen JT, Volicer L. Evaluating the feasibility and acceptability of the Namaste Care program in long-term care settings in Canada. Pilot and Feasibility Studies. 6: 34. PMID 32161658 DOI: 10.1186/S40814-020-00575-4  0.305
2018 Volicer L. Behavioral Problems and Dementia. Clinics in Geriatric Medicine. 34: 637-651. PMID 30336992 DOI: 10.1016/j.cger.2018.06.009  0.323
2017 Stacpoole M, Hockley J, Thompsell A, Simard J, Volicer L. Implementing the Namaste Care Program for residents with advanced dementia: exploring the perceptions of families and staff in UK care homes. Annals of Palliative Medicine. 6: 327-339. PMID 28754045 DOI: 10.21037/apm.2017.06.26  0.313
2016 Volicer L. Quality Of Life in Advanced Dementia Journal of Aging Science. 4: 1-2. DOI: 10.4172/2329-8847.1000E122  0.302
2015 van der Steen JT, Radbruch L, de Boer ME, Jünger S, Hughes JC, Larkin P, Gove D, Francke AL, Koopmans RT, Firth P, Volicer L, Hertogh CM. Achieving consensus and controversy around applicability of palliative care to dementia. International Psychogeriatrics / Ipa. 1-13. PMID 26060924 DOI: 10.1017/S1041610215000824  0.312
2015 Volicer L, Simard J. Palliative care and quality of life for people with dementia: medical and psychosocial interventions. International Psychogeriatrics / Ipa. 1-12. PMID 25573531 DOI: 10.1017/S1041610214002713  0.323
2015 Stacpoole M, Hockley J, Thompsell A, Simard J, Volicer L. The Namaste Care programme can reduce behavioural symptoms in care home residents with advanced dementia. International Journal of Geriatric Psychiatry. 30: 702-9. PMID 25338971 DOI: 10.1002/gps.4211  0.307
2015 Volicer L. Loving Touch: Treatment for Rejection of Care Journal of Aging Science. 3: 1-2. DOI: 10.4172/2329-8847.1000E116  0.319
2014 Volicer L, Stets K. Acceptability of an Advance Directive That Limits Food and Liquids in Advanced Dementia. The American Journal of Hospice & Palliative Care. PMID 25313239 DOI: 10.1177/1049909114554078  0.3
2014 van der Steen JT, Radbruch L, Hertogh CM, de Boer ME, Hughes JC, Larkin P, Francke AL, Jünger S, Gove D, Firth P, Koopmans RT, Volicer L. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliative Medicine. 28: 197-209. PMID 23828874 DOI: 10.1177/0269216313493685  0.311
2013 Vandervoort A, Van den Block L, van der Steen JT, Volicer L, Vander Stichele R, Houttekier D, Deliens L. Nursing home residents dying with dementia in Flanders, Belgium: a nationwide postmortem study on clinical characteristics and quality of dying. Journal of the American Medical Directors Association. 14: 485-92. PMID 23523319 DOI: 10.1016/j.jamda.2013.01.016  0.316
2013 Volicer L. Palliative care in dementia Progress in Palliative Care. 21: 146-150. DOI: 10.1179/1743291X12Y.0000000036  0.354
2012 Volicer L. Toward better terminology of behavioral symptoms of dementia. Journal of the American Medical Directors Association. 13: 3-4. PMID 21450232 DOI: 10.1016/j.jamda.2010.12.007  0.303
2009 Volicer L, Van der Steen JT, Frijters DH. Modifiable factors related to abusive behaviors in nursing home residents with dementia. Journal of the American Medical Directors Association. 10: 617-22. PMID 19883883 DOI: 10.1016/j.jamda.2009.06.004  0.321
2009 Mitchell SL, Teno JM, Kiely DK, Shaffer ML, Jones RN, Prigerson HG, Volicer L, Givens JL, Hamel MB. The clinical course of advanced dementia. The New England Journal of Medicine. 361: 1529-38. PMID 19828530 DOI: 10.1056/Nejmoa0902234  0.333
2009 McCarty CE, Volicer L. Hospice access for individuals with dementia. American Journal of Alzheimer's Disease and Other Dementias. 24: 476-85. PMID 19812416 DOI: 10.1177/1533317509348207  0.316
2009 van der Steen JT, Gijsberts MJ, Muller MT, Deliens L, Volicer L. Evaluations of end of life with dementia by families in Dutch and U.S. nursing homes. International Psychogeriatrics / Ipa. 21: 321-9. PMID 19193253 DOI: 10.1017/S1041610208008399  0.309
2007 Volicer L, Bass EA, Luther SL. Agitation and resistiveness to care are two separate behavioral syndromes of dementia. Journal of the American Medical Directors Association. 8: 527-32. PMID 17931577 DOI: 10.1016/j.jamda.2007.05.005  0.317
2007 Piechniczek-Buczek J, Riordan ME, Volicer L. Family member perception of quality of their visits with relatives with dementia: a pilot study. Journal of the American Medical Directors Association. 8: 166-72. PMID 17349945 DOI: 10.1016/j.jamda.2006.09.017  0.32
2006 van der Steen JT, Volicer L, Gerritsen DL, Kruse RL, Ribbe MW, Mehr DR. Defining severe dementia with the Minimum Data Set. International Journal of Geriatric Psychiatry. 21: 1099-106. PMID 16955417 DOI: 10.1002/gps.1618  0.316
2006 Kiely DK, Volicer L, Teno J, Jones RN, Prigerson HG, Mitchell SL. The validity and reliability of scales for the evaluation of end-of-life care in advanced dementia. Alzheimer Disease and Associated Disorders. 20: 176-81. PMID 16917188 DOI: 10.1097/00002093-200607000-00009  0.314
2006 Mitchell SL, Kiely DK, Jones RN, Prigerson H, Volicer L, Teno JM. Advanced dementia research in the nursing home: the CASCADE study. Alzheimer Disease and Associated Disorders. 20: 166-75. PMID 16917187 DOI: 10.1097/00002093-200607000-00008  0.331
2005 Hughes JC, Robinson L, Volicer L. Specialist palliative care in dementia. Bmj (Clinical Research Ed.). 330: 57-8. PMID 15637354 DOI: 10.1136/bmj.330.7482.57  0.324
2005 Robinson L, Hughes J, Daley S, Keady J, Ballard C, Volicer L. End-of-life care and dementia Reviews in Clinical Gerontology. 15: 135-148. DOI: 10.1017/S0959259806001833  0.327
2004 Harper DG, Stopa EG, McKee AC, Satlin A, Fish D, Volicer L. Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease. Neurobiology of Aging. 25: 771-81. PMID 15165702 DOI: 10.1016/J.Neurobiolaging.2003.04.009  0.311
2003 Volicer L, Hurley AC, Blasi ZV. Characteristics of dementia end-of-life care across care settings. The American Journal of Hospice & Palliative Care. 20: 191-200. PMID 12785040 DOI: 10.1177/104990910302000307  0.312
2002 Blasi ZV, Hurley AC, Volicer L. End-of-life care in dementia: a review of problems, prospects, and solutions in practice. Journal of the American Medical Directors Association. 3: 57-65. PMID 12807540 DOI: 10.1016/S1525-8610(04)70414-4  0.303
2001 Volicer L, Hurley AC, Blasi ZV. Scales for evaluation of End-of-Life Care in Dementia. Alzheimer Disease and Associated Disorders. 15: 194-200. PMID 11723370 DOI: 10.1097/00002093-200110000-00005  0.323
2001 Volicer L. Management of severe Alzheimer's disease and end-of-life issues. Clinics in Geriatric Medicine. 17: 377-91. PMID 11375141 DOI: 10.1016/S0749-0690(05)70074-4  0.317
2001 Harper DG, Stopa EG, McKee AC, Satlin A, Harlan PC, Goldstein R, Volicer L. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Archives of General Psychiatry. 58: 353-60. PMID 11296096 DOI: 10.1001/Archpsyc.58.4.353  0.321
2000 Hurley AC, Volicer L, Blasi ZV. End-of-life care for patients with advanced dementia. Jama. 284: 2449-50. PMID 11074773 DOI: 10.1001/Jama.284.19.2449-Jlt1115-6-1  0.327
2000 Volicer L, Hurley AC, Blasi ZV. Tools for evaluation of end-of-life care in dementia Neurobiology of Aging. 21: 231. DOI: 10.1016/S0197-4580(00)83374-6  0.307
1997 Volicer L. Hospice care for dementia patients. Journal of the American Geriatrics Society. 45: 1147-9. PMID 9288027 DOI: 10.1111/j.1532-5415.1997.tb05982.x  0.328
1997 Chen JC, Turiak G, Galler J, Volicer L. Postnatal changes of brain monoamine levels in prenatally malnourished and control rats. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 15: 257-63. PMID 9178043 DOI: 10.1016/S0736-5748(96)00121-9  0.473
1996 Hurley AC, Volicer BJ, Volicer L. Effect of fever-management strategy on the progression of dementia of the Alzheimer type. Alzheimer Disease and Associated Disorders. 10: 5-10. PMID 8919491 DOI: 10.1097/00002093-199601010-00003  0.335
1996 Chen JC, Fine RE, Squicciarini J, Volicer L. Neurotoxicity of free-radical-mediated serotonin neurotoxin in cultured embryonic chick brain neurons. European Journal of Pharmacology. 303: 109-14. PMID 8804918 DOI: 10.1016/0014-2999(96)00059-3  0.455
1995 Little JT, Satlin A, Sunderland T, Volicer L. Sundown syndrome in severely demented patients with probable Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 8: 103-6. PMID 7794472 DOI: 10.1177/089198879500800205  0.315
1995 Chen JC, Turiak G, Galler J, Volicer L. Effect of prenatal malnutrition on release of monoamines from hippocampal slices. Life Sciences. 57: 1467-75. PMID 7564891 DOI: 10.1016/0024-3205(95)02119-4  0.453
1995 Farrer LA, Abraham CR, Volicer L, Foley EJ, Kowall NW, McKee AC, Wells JM. Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Experimental Neurology. 136: 162-70. PMID 7498406 DOI: 10.1006/Exnr.1995.1093  0.301
1994 Blatt GJ, Chen JC, Rosene DL, Volicer L, Galler JR. Prenatal protein malnutrition effects on the serotonergic system in the hippocampal formation: an immunocytochemical, ligand binding, and neurochemical study. Brain Research Bulletin. 34: 507-18. PMID 8082044 DOI: 10.1016/0361-9230(94)90025-6  0.389
1994 Volicer L, Hurley AC, Lathi DC, Kowall NW. Measurement of severity in advanced Alzheimer's disease. Journal of Gerontology. 49: M223-6. PMID 8056941 DOI: 10.1093/Geronj/49.5.M223  0.313
1994 Volicer L, Collard A, Hurley A, Bishop C, Kern D, Karon S. Impact of special care unit for patients with advanced Alzheimer's disease on patients' discomfort and costs. Journal of the American Geriatrics Society. 42: 597-603. PMID 7515405 DOI: 10.1111/J.1532-5415.1994.Tb06856.X  0.309
1993 Volicer BJ, Hurley A, Fabiszewski KJ, Montgomery P, Volicer L. Predicting short-term survival for patients with advanced Alzheimer's disease. Journal of the American Geriatrics Society. 41: 535-40. PMID 8486888 DOI: 10.1111/J.1532-5415.1993.Tb01891.X  0.31
1993 Hurley AC, Volicer B, Mahoney MA, Volicer L. Palliative fever management in Alzheimer patients. quality plus fiscal responsibility. Ans. Advances in Nursing Science. 16: 21-32. PMID 7508704 DOI: 10.1097/00012272-199309000-00004  0.336
1992 de la Monte SM, Volicer L, Hauser SL, Wands JR. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology. 32: 733-42. PMID 1471863 DOI: 10.1002/Ana.410320606  0.314
1992 Chen JC, Schnepper PW, To A, Volicer L. Neurochemical changes in the rat brain after intraventricular administration of tryptamine-4,5-dione. Neuropharmacology. 31: 215-9. PMID 1378572 DOI: 10.1016/0028-3908(92)90170-T  0.473
1992 Chen JC, Tonkiss J, Galler JR, Volicer L. Prenatal protein malnutrition in rats enhances serotonin release from hippocampus. The Journal of Nutrition. 122: 2138-43. PMID 1279142 DOI: 10.1093/Jn/122.11.2138  0.393
1991 Fishman JB, Rubins JB, Chen JC, Dickey BF, Volicer L. Modification of brain guanine nucleotide-binding regulatory proteins by tryptamine-4,5-dione, a neurotoxic derivative of serotonin. Journal of Neurochemistry. 56: 1851-4. PMID 1902871 DOI: 10.1111/J.1471-4159.1991.Tb03440.X  0.45
1991 Vogt BA, Crino PB, Volicer L. Laminar alterations in gamma-aminobutyric acidA, muscarinic, and beta adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease. Journal of Neurochemistry. 57: 282-90. PMID 1675662 DOI: 10.1111/j.1471-4159.1991.tb02126.x  0.471
1990 Volicer L, Crino PB. Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiology of Aging. 11: 567-71. PMID 2146522 DOI: 10.1016/0197-4580(90)90119-K  0.534
1990 Crino PB, Vogt BA, Volicer L, Wiley RG. Cellular localization of serotonin 1A, 1B and uptake sites in cingulate cortex of the rat. The Journal of Pharmacology and Experimental Therapeutics. 252: 651-6. PMID 2138221  0.466
1990 Cai P, Snyder JK, Chen JC, Fine R, Volicer L. Preparation, reactivity, and neurotoxicity of tryptamine-4,5-dione Tetrahedron Letters. 31: 969-972. DOI: 10.1016/S0040-4039(00)94405-8  0.446
1989 Crino PB, Ullman MD, Vogt BA, Bird ED, Volicer L. Brain gangliosides in dementia of the Alzheimer type. Archives of Neurology. 46: 398-401. PMID 2705899 DOI: 10.1001/archneur.1989.00520400054019  0.559
1989 Crino PB, Vogt BA, Chen JC, Volicer L. Neurotoxic effects of partially oxidized serotonin: tryptamine-4,5-dione. Brain Research. 504: 247-57. PMID 2598027 DOI: 10.1016/0006-8993(89)91364-4  0.576
1989 Volicer L, Seltzer B, Rheaume Y, Karner J, Glennon M, Riley ME, Crino P. Eating difficulties in patients with probable dementia of the Alzheimer type. Journal of Geriatric Psychiatry and Neurology. 2: 188-95. PMID 2483945 DOI: 10.1177/089198878900200404  0.541
1989 Volicer L, Chen JC, Crino PB, Vogt BA, Fishman J, Rubins J, Schenepper PW, Wolfe N. Neurotoxic properties of a serotonin oxidation product: possible role in Alzheimer's disease. Progress in Clinical and Biological Research. 317: 453-65. PMID 2481322 DOI: 10.1097/00002093-198802030-00090  0.632
1989 Chen JC, Crino PB, Schnepper PW, To AC, Volicer L. Increased serotonin efflux by a partially oxidized serotonin: tryptamine-4,5-dione. The Journal of Pharmacology and Experimental Therapeutics. 250: 141-8. PMID 2473186  0.58
1986 Volicer L, Rheaume Y, Brown J, Fabiszewski K, Brady R. Hospice approach to the treatment of patients with advanced dementia of the Alzheimer type. Jama. 256: 2210-3. PMID 3761520 DOI: 10.1001/jama.256.16.2210  0.345
1986 Zubenko GS, Marquis JK, Volicer L, Direnfeld LK, Langlais PJ, Nixon RA. Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study. Biological Psychiatry. 21: 1365-81. PMID 3024746 DOI: 10.1016/0006-3223(86)90328-8  0.305
1985 Marquis JK, Volicer L, Mark KA, Direnfeld LK, Freedman M. Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type. Biological Psychiatry. 20: 605-10. PMID 3995108 DOI: 10.1016/0006-3223(85)90095-2  0.301
1985 Volicer L, Direnfeld LK, Langlais PJ, Freedman M, Bird ED, Albert ML. Catecholamine metabolites and cyclic nucleotides in cerebrospinal fluid in dementia of Alzheimer type. Journal of Gerontology. 40: 708-13. PMID 2997317 DOI: 10.1093/Geronj/40.6.708  0.304
Show low-probability matches.